Loading...
Loading...
Browse all stories on DeepNewz
VisitHow will Mankind Pharma's market share change by end of 2025?
Mankind Pharma becomes the largest drug maker • 25%
Mankind Pharma becomes the second largest drug maker • 25%
Mankind Pharma remains the fourth largest drug maker • 25%
Mankind Pharma's ranking declines • 25%
Market share data from industry reports or financial news outlets
Mankind Pharma Secures CCI Approval for ₹13,360 Crore Bharat Serums Acquisition
Oct 2, 2024, 02:01 AM
Mankind Pharma has received approval from the Competition Commission of India (CCI) for its acquisition of Bharat Serums and Vaccines Limited. The acquisition deal is valued at ₹13,360 crore (approximately $1.6 billion), though some reports indicate a value of Rs 13,630 crore. This transaction involves Mankind Pharma acquiring 100% shareholding of Bharat Serums and Vaccines Limited. Mankind Pharma is India's fourth-largest drug maker.
View original story
Pfizer • 33%
Johnson & Johnson • 33%
Eli Lilly • 33%
Yes • 50%
No • 50%
Increase by > 5% • 25%
Increase by ≤ 5% • 25%
Decrease by ≤ 5% • 25%
Decrease by > 5% • 25%
Mounjaro > 50% • 25%
Mounjaro 30-50% • 25%
Mounjaro 10-30% • 25%
Mounjaro < 10% • 25%
Top 5 • 25%
Rank 6-10 • 25%
Rank 11-15 • 25%
Below 15 • 25%
Top 1 • 25%
Top 2-5 • 25%
Top 6-10 • 25%
Outside top 10 • 25%
Increase by more than 5% • 25%
Decrease by more than 5% • 25%
Remain roughly the same • 25%
Other • 25%
Top 3 • 25%
4th to 6th • 25%
7th to 10th • 25%
Outside top 10 • 25%
Increase • 25%
Remain the same • 25%
Decrease • 25%
Other • 25%
Increase by 1% or more • 25%
No significant change • 25%
Decrease by up to 1% • 25%
Decrease by more than 1% • 25%
Increase by more than 5% • 25%
Increase by 1-5% • 25%
No significant change • 25%
Decrease • 25%
No further acquisitions • 25%
Three or more additional acquisitions • 25%
Two additional acquisitions • 25%
One additional acquisition • 25%